Skip to main content

Collaborate to Innovate: London Diagnostics

Our new 12-month programme helps diagnostics entrepreneurs progress their R&D, test, validate, scale-up, and implement their products. Applications are invited from diagnostics innovators based in London—at start-up or SME stage.

Log in to your account

How it works

This year-long programme offers collaborative opportunities and grant-funded support for up to 10 London-based SMEs with a valid diagnostic innovation. Each SME is introduced to world-leading partners for matchmaking with: academics; clinical researchers; major diagnostics companies; medical research charities; and evidence generation authorities. Through this matchmaking process, the SME forms an objective-driven research project, tapping into cross-sector industry knowledge that is otherwise difficult to access. Translational support includes guidance on validation, testing and evidence standards.

APPLICATIONS FOR 2021 ARE NOW CLOSED. Please get in touch via our contact form if you are interested in joining our DIAGNOSTICS GROWTH HUB

EXISTING APPLICANTS: LOG IN TO YOUR ACCOUNT HERE

DOWNLOAD APPLICATION GUIDANCE NOTES HERE

Grant funded by

Who can apply?

We are inviting applications from diagnostic developers based in London, with proof of concept as a minimum requirement. We are especially interested in diagnostics addressing disease areas prevalent in London, including the following key areas: Infectious and respiratory diseases (COVID-19 and other novel pathogens); oncology; cardiovascular disease.

Applications will be assessed on the following criteria:

  • Clinical need for the technology
  • Impact of the technology – e.g., speed to market, who/what areas it will serve
  • Credibility of the collaborative team to deliver the project
  • Utilisation of grant funding – value based on robustness of budgeted financial profile/plan

1.

APPLICATIONS ARE NOW CLOSED

2.

MATCHMAKING: During stage 1 in July/August, eligible applicants will meet specialists across the sector to explore potential collaboration. In stage 2, applicants will have the opportunity to form collaborative research teams and define the scope of their proposed projects.

3.

SELECTION & START: Finalists will be notified and contracts will be signed by the end of November. Teams start their 12-month research projects in December.

DOWNLOAD APPLICATION GUIDANCE NOTES HERE

MedCity’s Collaborate to Innovate programme has a proven track record of helping SMEs progress from early development to market readiness. Find out more about our previous and current cohorts in other life science sectors:

Broad life sciences

Advanced therapies

Stroke-related innovations

Delivery Partners

Supported by:

Contact us